Coverage
-
January 18, 2022
An Illinois federal judge granted OncoGenerix USA Inc. summary judgment on almost all claims in a suit alleging it violated an agreement with Meridian Laboratories Inc. to help develop a cancer treatment, saying Meridian can't back up its allegations that OncoGenerix misappropriated its confidential information.
2 other articles on this case.
View all »